Overview (18 Sep 2026)
Lyka Labs Ltd
LYKALABS
INE933A01014

Pharmaceuticals
Result was last declared on 01 Aug 2025
1.63

Prev. Close
Previous Close
81.71
Current Close
83.34
Current High
83.34
Current Low
83.34
52 Week High
104.8
52 Week Low
44.49
Resistance 1
83.34
Resistance 2
83.34
Support 1
83.34
Support 2
83.34
Std Deviation
7.92%
DMA 200
67.89
DMA 50
71.21
DMA 20
77.98
Fundamentals and Ratios
Standalone
Trailing EPS
0
Forwad EPS
-10.45
Trailing P/E
NA
Forward P/E
NA
PEG Ratio
2.41
Mkt. Cap (Cr)
Market Cap (Cr)
301.3
Total Debt(Cr)
Tot. Debt(Cr)
48.36
Reserve (Cr)
56.70
Book Value
25.52
P/BV Ratio
3.27
ROCE(%)
-21.00
ROE
-31.00
Consolidated
Trailing EPS
0
Forwad EPS
-2.13
Trailing P/E
1.08
Forward P/E
-39.07
PEG Ratio
2.93
Mkt. Cap (Cr)
Market Cap (Cr)
301.3
Total Debt(Cr)
Tot. Debt(Cr)
48.36
Reserve (Cr)
56.70
Book Value
25.52
P/BV Ratio
3.27
ROCE(%)
-2.36
ROE
-10.1500

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue42.3128.0330.7332.9729.18120.91
Other Income0.420.511.261.220.673.97
Total Income42.7328.5431.9934.1929.84124.88
Interest1.010.870.820.790.853.33
Expenditure-40.73-35.43-31.71-38.98-28.67-135.10
PBDT0.000.000.000.000.000.00
Depreciation-2.01-2.04-2.08-2.07-2.03-8.46
PBT1.99-29.900.28-4.801.17-33.24
Tax0.110.130.001.17-0.360.95
Equity36.1535.690.000.0035.6935.69
OPM4.66-104.770.90-14.553.92-26.61
Net Profit2.1-29.770.28-3.630.81-32.29
NPM4.91-104.310.91-112.71-25.86
EPS0.58-8.50.08-1.020.220
Consolidated
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue42.3128.0330.7336.6633.03128.445
Other Income0.420.611.161.090.633.50
Total Income42.7328.6431.8937.7533.66131.94
Interest1.010.700.820.790.853.33
Expenditure-40.78-37.23-32.05-42.14-32.30-143.72
PBDT0.000.000.000.000.000.00
Depreciation-2.01-2.04-2.16-2.15-2.11-8.46
PBT1.95-8.590.000.001.35-11.78
Tax0.100.520.011.17-0.361.34
Equity36.1535.690.000.0035.6935.69
OPM4.56-29.990.000.004.01-8.93
Net Profit2.05-8.07-0.15-3.211-10.44
NPM4.8-28.18-0.47-8.512.97-7.91
EPS0.57-2.130-0.940.250
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings